InvestorsHub Logo
Followers 32
Posts 5215
Boards Moderated 0
Alias Born 03/25/2013

Re: rafunrafun post# 273591

Thursday, 05/14/2020 1:00:40 PM

Thursday, May 14, 2020 1:00:40 PM

Post# of 424038
Totally agree with this. Amicus briefs might flesh out the story from different angles that Singer is not allowed to explore on an appeal. Hopefully painting a picture of this drug not being promoted to US patients if the company responsible is not given patent protection.

In a perfect world we'd see briefs from the ADA, ACC, AHA, ICER, the USPTO, and any BP that doesn't want to be sitting in Amarin's spot when generics come for their new drug using this case as precedent.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News